Literature DB >> 15718414

Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Carlos H C Serezani1, David M Aronoff, Sonia Jancar, Peter Mancuso, Marc Peters-Golden.   

Abstract

Leukotrienes (LTs) are lipid mediators that participate in inflammatory diseases and innate immune function. We sought to investigate the importance of LTs in regulating the microbicidal activity of alveolar macrophages (AMs) and the molecular mechanisms by which this occurs. The role of LTs in enhancing AM microbicidal activity was evaluated pharmacologically and genetically using in vitro challenge with Klebsiella pneumoniae. Exogenous LTs increased AM microbicidal activity in a dose- and receptor-dependent manner, and endogenous production of LTs was necessary for optimal killing. Leukotriene B4 (LTB4) was more potent than cysteinyl LTs. An important role for nicotinamide adenine dinucleotide (NADPH) oxidase in LT-induced microbicidal activity was indicated by the fact that bacterial killing was abrogated by the NADPH oxidase inhibitor diphenyleneiodonium (DPI; 10 microM) and in AMs derived from gp91phox-deficient mice. By contrast, LT-induced microbicidal activity was independent of the generation of nitric oxide. LTs increased H2O2 production, and LTB4 was again the more potent agonist. Both classes of LTs elicited translocation of p47phox to the cell membrane, and LTB4 induced phosphorylation of p47phox in a manner dependent on protein kinase C-delta (PKC-delta) activity. In addition, the enhancement of microbicidal activity by LTs was also dependent on PKC-delta activity. Our results demonstrate that LTs, especially LTB4, enhanceAM microbicidal activity through the PKC-delta-dependent activation of NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718414      PMCID: PMC1895163          DOI: 10.1182/blood-2004-08-3323

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

Review 1.  Macrophage defences against respiratory tract infections.

Authors:  S B Gordon; R C Read
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

2.  Depressant effect of ambroxol on stimulated functional responses and cell death in rat alveolar macrophages exposed to silica in vitro.

Authors:  Young Ki Kim; Yoon Young Jang; Eun Sook Han; Chung Soo Lee
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

3.  Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis.

Authors:  Chang-Hoon Woo; Hye-Jin You; Sung-Hoon Cho; Young-Woo Eom; Jang-Soo Chun; Yung-Joon Yoo; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

Review 4.  Study of NADPH oxidase-activated sites in human neutrophils.

Authors:  Harumichi Seguchi; Toshihiro Kobayashi
Journal:  J Electron Microsc (Tokyo)       Date:  2002

5.  Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta.

Authors:  J L Bankers-Fulbright; H Kita; G J Gleich; S M O'Grady
Journal:  J Cell Physiol       Date:  2001-12       Impact factor: 6.384

6.  Killing of Klebsiella pneumoniae by human alveolar macrophages.

Authors:  Judy M Hickman-Davis; Philip O'Reilly; Ian C Davis; Janos Peti-Peterdi; Glenda Davis; K Randall Young; Robert B Devlin; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-05       Impact factor: 5.464

7.  Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia.

Authors:  Peter Mancuso; Andrew Gottschalk; Susan M Phare; Marc Peters-Golden; Nicholas W Lukacs; Gary B Huffnagle
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

8.  Phagocytosis and bactericidal action of mouse peritoneal macrophages treated with leukotriene B4.

Authors:  T Demitsu; H Katayama; T Saito-Taki; H Yaoita; M Nakano
Journal:  Int J Immunopharmacol       Date:  1989

9.  Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox).

Authors:  Xiaoxian Zhao; Erik A Bey; Frans B Wientjes; Martha K Cathcart
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

10.  Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.

Authors:  A Talvani; F S Machado; G C Santana; A Klein; L Barcelos; J S Silva; M M Teixeira
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  77 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.

Authors:  Sanjay Batra; Shanshan Cai; Gayathriy Balamayooran; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

Review 3.  Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species.

Authors:  Kyung-Jin Cho; Ji-Min Seo; Jae-Hong Kim
Journal:  Mol Cells       Date:  2011-03-18       Impact factor: 5.034

Review 4.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

5.  Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.

Authors:  Emanuela Greco; Gianluca Quintiliani; Marilina B Santucci; Annalucia Serafino; Anna Rita Ciccaglione; Cinzia Marcantonio; Massimiliano Papi; Giuseppe Maulucci; Giovanni Delogu; Angelo Martino; Delia Goletti; Loredana Sarmati; Massimo Andreoni; Alfonso Altieri; Mario Alma; Nadia Caccamo; Diana Di Liberto; Marco De Spirito; Nigel D Savage; Roberto Nisini; Francesco Dieli; Tom H Ottenhoff; Maurizio Fraziano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

6.  Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.

Authors:  Anju Singh; Tabassum Rahman; Rose Bartiss; Alireza Arabshahi; Jeevan Prasain; Stephen Barnes; Florin Marcel Musteata; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

7.  E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection.

Authors:  David M Aronoff; Casey Lewis; Carlos H Serezani; Kathryn A Eaton; Deepti Goel; John C Phipps; Marc Peters-Golden; Peter Mancuso
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

8.  Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Authors:  Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

9.  Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain.

Authors:  Longkun Zhu; Ravi Maruvada; Adam Sapirstein; Marc Peters-Golden; Kwang Sik Kim
Journal:  Cell Microbiol       Date:  2016-09-25       Impact factor: 3.715

10.  Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.

Authors:  Megan N Ballinger; Leah L N Hubbard; Tracy R McMillan; Galen B Toews; Marc Peters-Golden; Robert Paine; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.